0
     

Report Added
Report already added
Global Liquid Biopsy Market By Offering (Testing Services, Kits, Platform, Other consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Others), By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management), By Sample (Blood, Urine, Saliva, Others), By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Cell-free Nucleic Acids, Exosomes & Extracellular Vesicles), By Application (Oncological and Non-oncological), By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), By Region Competition Forecast & Opportunities, 2027

Global Liquid Biopsy Market By Offering (Testing Services, Kits, Platform, Other consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Others), By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management), By Sample (Blood, Urine, Saliva, Others), By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Cell-free Nucleic Acids, Exosomes & Extracellular Vesicles), By Application (Oncological and Non-oncological), By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), By Region Competition Forecast & Opportunities, 2027

Global liquid biopsy market was valued at USD 2,728.57 million in 2021, and during the forecast period, it is expected to expand at a CAGR of 13.77%. An alternate way of detecting and diagnosing cancer is liquid biopsy. The primary reason propelling the growth of the liquid biopsy market is the rising incidence of cancer worldwide. Liquid biopsies aid in the early detection of cancer while traditional biopsy techniques do not allow the detection of cancer in the aged population.
Due to factors such as the rising prevalence of cancer, increased funding for research to find new biomarkers, and increased emphasis on the use of liquid biopsy, the market is anticipated to experience rapid expansion.
The rise of the industry is partly a result of substantial investments made by biotechnology firms in the research and development of liquid biopsies. A further factor driving the growth of the liquid biopsy market in the years to come is the increasing use of liquid biopsy among prominent end users.
Rising Incidence of Cancer
Several factors, including tobacco use, alcohol use, poor food, physical inactivity, and air pollution, are contributing to the rise in cancer cases in the modern world. The global incidence of cancer is rising, making it the second biggest cause of death. Breast cancer is now the most prevalent type of cancer diagnosed worldwide due to the increased prevalence of the disease among females.
Growing adoption of Liquid Biopsy among major end users
As prospective screening, diagnostic, prognostic, and predictive tests in cancer, liquid biopsies have gained a lot of interest. Clinical oncology has undergone a significant revolution owing to liquid biopsy, which makes it easier to sample tumors, provide continuous monitoring through repeated sampling, enable the creation of specific treatment plans, and test for therapeutic resistance. Since most cancers are in contact with blood, liquid biopsy mostly includes blood collection, though mucosa, pleural effusions, urine, and cerebrospinal fluid (CSF) are also examined during the procedure. As a result, Liquid Biopsy offers improved diagnosis sensitivity and simplicity of recurring sampling throughout therapy in a far more practical and non-invasive manner.
Increased Awareness Regarding Cancer
Today's population is more aware of the signs and symptoms of cancer, and they try to have their illness diagnosed when it is still in its early stages. As a result of early cancer detection, tumor progression monitoring, and clinical prognosis assessment capabilities, liquid biopsy technology is experiencing market expansion.
Market Segmentation
The Global Liquid Biopsy Market is segmented based on Offering, Technology, Workflow, Sample, Circulating Biomarker, Application, End User, and Region. Based on Offering, the market can be split into Testing Service, Kits, Platform, Other Consumables. Based on Technology, the market can be divided into Next Generation Sequencing, Polymerase Chain Reactions, Others. Based on Workflow, the market is divided into Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management. Based on Sample, the market is divided into Blood, Urine, Saliva, Others.
Based on Circulating Biomarker, the market is divided into Circulating Tumor Cells (CTCs), Cell Free RNAs, Exosomes & Extracellular Vesicles, Others. In terms of Application, the market can be categorized into Oncological v/s non-Oncological. Based on End User, the market is split into Pharmaceutical & Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes.
Company Profiles
F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., PerkinElmer Inc., LungLife AI, Inc., Illumina, Inc., QIAGEN NV, NeoGenomics Laboratories, Inc., Myriad Genetics, Inc., Biocept, Inc., Bio-Rad Laboratories, Inc., Guardant Health Inc., Natera, Inc., Sysmex Corporation, Abcodia Ltd., Dxcover Limited are among some of the major market players in the Global Liquid Biopsy Market.
Report Scope:
In this report, Global Liquid Biopsy Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Liquid Biopsy Market, By Offering:
oTesting Service
oKits
oPlatform
oOther consumables
•Liquid Biopsy Market, By Technology:
oPolymerase Chain Reaction
oNext Generation Sequencing
oOthers
•Liquid Biopsy Market, By Workflow:
oSample Preparation
oLibrary Preparation
oSequencing
oData Analysis & Management
•Liquid Biopsy Market, By Sample:
oBlood
oUrine
oSaliva
oOthers
•Liquid Biopsy Market, By Circulating Biomarkers:
oCirculating Tumor Cells (CTCs)
oCell-free Nucleic Acids
oExosomes & Extracellular Vesicles
oOthers
•Liquid Biopsy Market, By Application:
oOncological
oNon- Oncological
•Liquid Biopsy Market, By Region:
oNorth America
United States
Canada
Mexico
oEurope
Germany
France
United Kingdom
Italy
Spain
Netherlands
Belgium
Denmark
oAsia-Pacific
China
India
Japan
South Korea
Australia
New Zealand
oSouth America
Brazil
Argentina
Colombia
oMiddle East & Africa
Turkey
Egypt
Saudi Arabia
South Africa
UAE
Competitive Landscape:
Company Profiles: Detailed analysis of the major companies present in Global Liquid Biopsy market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).
Table of Contents

1.Product Overview
2.Research Methodology
3.Executive Summary
4.Impact of COVID-19 on Global Liquid Biopsy Market
5.Voice of Customer
5.1.Cancer Prevalence, By Gender
5.2.Cancer Prevalence, By Age Group
5.3.Cancer Prevalence, By Region
5.4.Common Methods Used for Cancer Detection
5.5.Benefits of Using Liquid Biopsy
5.6.Barriers to Adoption of Liquid Biopsy
6.Clinical Trial Analysis
7.Patent Analysis
8.Global Liquid Biopsy Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Offering (Testing Service, Kits, Platform, Other Consumables)
8.2.2.By Technology (Polymerase Chain Reactions, Next Generation Sequencing, Others)
8.2.3.By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management)
8.2.4.By Sample (Blood, Urine, Saliva, Others)
8.2.5.By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free Nucleic Acids, Exosomes & Extracellular Vesicles, Others)
8.2.6.By Application (Oncological v/s non-Oncological)
8.2.6.1.By Oncological (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Others)
8.2.6.2.By Non-Oncological (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others)
8.2.7.By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies)
8.2.8.By Company (2021)
8.2.9.By Region
8.3.Market Map
9.North America Liquid Biopsy Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Offering (Testing Service, Kits, Platform, Other Consumables)
9.2.2.By Technology (Polymerase Chain Reactions, Next Generation Sequencing, Others)
9.2.3.By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management)
9.2.4.By Sample (Blood, Urine, Saliva, Others)
9.2.5.By Circulating Biomarker (Circulating Tumour Cells (CTCs), Cell Free Nucleic Acids, Exosomes & Extracellular Vesicles, Others)
9.2.6.By Application (Oncological v/s non-Oncological)
9.2.6.1.By Oncological (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Others)
9.2.6.2.By Non-Oncological (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others)
9.2.7.By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies)
9.2.8.By Country
9.3.North America: Country Analysis
9.3.1.United States Liquid Biopsy Market Outlook
9.3.1.1.Market Size & Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share & Forecast
9.3.1.2.1.By Offering
9.3.1.2.2.By Technology
9.3.1.2.3.By Workflow
9.3.1.2.4.By Sample
9.3.1.2.5.By Circulating Biomarker
9.3.1.2.6.By Application
9.3.1.2.7.By End User
9.3.2.Canada Liquid Biopsy Market Outlook
9.3.2.1.Market Size & Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share & Forecast
9.3.2.2.1.By Offering
9.3.2.2.2.By Technology
9.3.2.2.3.By Workflow
9.3.2.2.4.By Sample
9.3.2.2.5.By Circulating Biomarker
9.3.2.2.6.By Application
9.3.2.2.7.By End User
9.3.3.Mexico Liquid Biopsy Market Outlook
9.3.3.1.Market Size & Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share & Forecast
9.3.3.2.1.By Offering
9.3.3.2.2.By Technology
9.3.3.2.3.By Workflow
9.3.3.2.4.By Sample
9.3.3.2.5.By Circulating Biomarker
9.3.3.2.6.By Application
9.3.3.2.7.By End User
10.Europe Liquid Biopsy Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Offering (Testing Service, Kits, Platform, Other Consumables)
10.2.2.By Technology (Polymerase Chain Reactions, Next Generation Sequencing, Others)
10.2.3.By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management)
10.2.4.By Sample (Blood, Urine, Saliva, Others)
10.2.5.By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free Nucleic Acids, Exosomes & Extracellular Vesicles, Others)
10.2.6.By Application (Oncological v/s non-Oncological)
10.2.6.1.By Oncological (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Others)
10.2.6.2.By Non-Oncological (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others)
10.2.7.By End User (Academic & Research Institutes, Clinical Laboratories, , Pharmaceutical & Biotechnology Companies)
10.2.8.By Country
10.3.Europe: Country Analysis
10.3.1.Germany Liquid Biopsy Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.By Offering
10.3.1.2.2.By Technology
10.3.1.2.3.By Workflow
10.3.1.2.4.By Sample
10.3.1.2.5.By Circulating Biomarker
10.3.1.2.6.By Application
10.3.1.2.7.By End User
10.3.2.France Liquid Biopsy Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.By Offering
10.3.2.2.2.By Technology
10.3.2.2.3.By Workflow
10.3.2.2.4.By Sample
10.3.2.2.5.By Circulating Biomarker
10.3.2.2.6.By Application
10.3.2.2.7.By End User
10.3.3.United Kingdom Liquid Biopsy Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.By Offering
10.3.3.2.2.By Technology
10.3.3.2.3.By Workflow
10.3.3.2.4.By Sample
10.3.3.2.5.By Circulating Biomarker
10.3.3.2.6.By Application
10.3.3.2.7.By End User
10.3.4.Italy Liquid Biopsy Market Outlook
10.3.4.1.Market Size & Forecast
10.3.4.1.1.By Value
10.3.4.2.Market Share & Forecast
10.3.4.2.1.By Offering
10.3.4.2.2.By Technology
10.3.4.2.3.By Workflow
10.3.4.2.4.By Sample
10.3.4.2.5.By Circulating Biomarker
10.3.4.2.6.By Application
10.3.4.2.7.By End User
10.3.5.Spain Liquid Biopsy Market Outlook
10.3.5.1.Market Size & Forecast
10.3.5.1.1.By Value
10.3.5.2.Market Share & Forecast
10.3.5.2.1.By Offering
10.3.5.2.2.By Technology
10.3.5.2.3.By Workflow
10.3.5.2.4.By Sample
10.3.5.2.5.By Circulating Biomarker
10.3.5.2.6.By Application
10.3.5.2.7.By End User
10.3.6.Netherlands Liquid Biopsy Market Outlook
10.3.6.1.Market Size & Forecast
10.3.6.1.1.By Value
10.3.6.2.Market Share & Forecast
10.3.6.2.1.By Offering
10.3.6.2.2.By Technology
10.3.6.2.3.By Workflow
10.3.6.2.4.By Sample
10.3.6.2.5.By Circulating Biomarker
10.3.6.2.6.By Application
10.3.6.2.7.By End User
10.3.7.Belgium Liquid Biopsy Market Outlook
10.3.7.1.Market Size & Forecast
10.3.7.1.1.By Value
10.3.7.2.Market Share & Forecast
10.3.7.2.1.By Offering
10.3.7.2.2.By Technology
10.3.7.2.3.By Workflow
10.3.7.2.4.By Sample
10.3.7.2.5.By Circulating Biomarker
10.3.7.2.6.By Application
10.3.7.2.7.By End User
10.3.8.Denmark Liquid Biopsy Market Outlook
10.3.8.1.Market Size & Forecast
10.3.8.1.1.By Value
10.3.8.2.Market Share & Forecast
10.3.8.2.1.By Offering
10.3.8.2.2.By Technology
10.3.8.2.3.By Workflow
10.3.8.2.4.By Sample
10.3.8.2.5.By Circulating Biomarker
10.3.8.2.6.By Application
10.3.8.2.7.By End User
11.Asia-Pacific Liquid Biopsy Market Outlook
11.1.Market Size & Forecast
11.1.1.By Value
11.2.Market Share & Forecast
11.2.1.By Offering (Testing Service, Kits, Platform, Other Consumables)
11.2.2.By Technology (Polymerase Chain Reactions, Next Generation Sequencing, Others)
11.2.3.By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management)
11.2.4.By Sample (Blood, Urine, Saliva, Others)
11.2.5.By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free Nucleic Acids, Exosomes & Extracellular Vesicles, Others)
11.2.6.By Application (Oncological v/s non-Oncological)
11.2.6.1.By Oncological (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Others)
11.2.6.2.By Non-Oncological (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others)
11.2.7.By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies)
11.2.8.By Country
11.3.Asia-Pacific: Country Analysis
11.3.1.China Liquid Biopsy Market Outlook
11.3.1.1.Market Size & Forecast
11.3.1.1.1.By Value
11.3.1.2.Market Share & Forecast
11.3.1.2.1.By Offering
11.3.1.2.2.By Technology
11.3.1.2.3.By Workflow
11.3.1.2.4.By Sample
11.3.1.2.5.By Circulating Biomarker
11.3.1.2.6.By Application
11.3.1.2.7.By End User
11.3.2.India Liquid Biopsy Market Outlook
11.3.2.1.Market Size & Forecast
11.3.2.1.1.By Value
11.3.2.2.Market Share & Forecast
11.3.2.2.1.By Offering
11.3.2.2.2.By Technology
11.3.2.2.3.By Workflow
11.3.2.2.4.By Sample
11.3.2.2.5.By Circulating Biomarker
11.3.2.2.6.By Application
11.3.2.2.7.By End User
11.3.3.Japan Liquid Biopsy Market Outlook
11.3.3.1.Market Size & Forecast
11.3.3.1.1.By Value
11.3.3.2.Market Share & Forecast
11.3.3.2.1.By Offering
11.3.3.2.2.By Technology
11.3.3.2.3.By Workflow
11.3.3.2.4.By Sample
11.3.3.2.5.By Circulating Biomarker
11.3.3.2.6.By Application
11.3.3.2.7.By End User
11.3.4.South Korea Liquid Biopsy Market Outlook
11.3.4.1.Market Size & Forecast
11.3.4.1.1.By Value
11.3.4.2.Market Share & Forecast
11.3.4.2.1.By Offering
11.3.4.2.2.By Technology
11.3.4.2.3.By Workflow
11.3.4.2.4.By Sample
11.3.4.2.5.By Circulating Biomarker
11.3.4.2.6.By Application
11.3.4.2.7.By End User
11.3.5.Australia Liquid Biopsy Market Outlook
11.3.5.1.Market Size & Forecast
11.3.5.1.1.By Value
11.3.5.2.Market Share & Forecast
11.3.5.2.1.By Offering
11.3.5.2.2.By Technology
11.3.5.2.3.By Workflow
11.3.5.2.4.By Sample
11.3.5.2.5.By Circulating Biomarker
11.3.5.2.6.By Application
11.3.5.2.7.By End User
11.3.6.New Zealand Liquid Biopsy Market Outlook
11.3.6.1.Market Size & Forecast
11.3.6.1.1.By Value
11.3.6.2.Market Share & Forecast
11.3.6.2.1.By Offering
11.3.6.2.2.By Technology
11.3.6.2.3.By Workflow
11.3.6.2.4.By Sample
11.3.6.2.5.By Circulating Biomarker
11.3.6.2.6.By Application
11.3.6.2.7.By End User
12.South America Liquid Biopsy Market Outlook
12.1.Market Size & Forecast
12.1.1.By Value
12.2.Market Share & Forecast
12.2.1.By Offering (Testing Service, Kits, Platform, Other Consumables)
12.2.2.By Technology (Next Generation Sequencing, Polymerase Chain Reactions, Others)
12.2.3.By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management)
12.2.4.By Sample (Blood, Urine, Saliva, Others)
12.2.5.By Circulating Biomarker (Circulating Tumour Cells (CTCs), Cell Free Nucleic Acids, Exosomes & Extracellular Vesicles, Others)
12.2.6.By Application (Oncological v/s non-Oncological)
12.2.6.1.By Oncological (Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Others)
12.2.6.2.By Non-Oncological (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others)
12.2.7.By End User (Pharmaceutical & Biotechnology Companies, Clinical Laboratories, Academic & Research Institutions)
12.2.8.By Country
12.3.South America: Country Analysis
12.3.1.Brazil Liquid Biopsy Market Outlook
12.3.1.1.Market Size & Forecast
12.3.1.1.1.By Value
12.3.1.2.Market Share & Forecast
12.3.1.2.1.By Offering
12.3.1.2.2.By Technology
12.3.1.2.3.By Workflow
12.3.1.2.4.By Sample
12.3.1.2.5.By Circulating Biomarker
12.3.1.2.6.By Application
12.3.1.2.7.By End User
12.3.2.Argentina Liquid Biopsy Market Outlook
12.3.2.1.Market Size & Forecast
12.3.2.1.1.By Value
12.3.2.2.Market Share & Forecast
12.3.2.2.1.By Offering
12.3.2.2.2.By Technology
12.3.2.2.3.By Workflow
12.3.2.2.4.By Sample
12.3.2.2.5.By Circulating Biomarker
12.3.2.2.6.By Application
12.3.2.2.7.By End User
12.3.3.Colombia Liquid Biopsy Market Outlook
12.3.3.1.Market Size & Forecast
12.3.3.1.1.By Value
12.3.3.2.Market Share & Forecast
12.3.3.2.1.By Offering
12.3.3.2.2.By Technology
12.3.3.2.3.By Workflow
12.3.3.2.4.By Sample
12.3.3.2.5.By Circulating Biomarker
12.3.3.2.6.By Application
12.3.3.2.7.By End User
13.Middle East and Africa Liquid Biopsy Market Outlook
13.1.Market Size & Forecast
13.1.1.By Value
13.2.Market Share & Forecast
13.2.1.By Offering (Testing Service, Kits, Platform, Other Consumables)
13.2.2.By Technology (Next Generation Sequencing, Polymerase Chain Reactions, Others)
13.2.3.By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management)
13.2.4.By Sample (Blood, Urine, Saliva, Others)
13.2.5.By Circulating Biomarker (Circulating Tumour Cells (CTCs), Circulating Cell Free RNAs, Exosomes & Extracellular Vesicles, Others)
13.2.6.By Application (Oncological v/s non-Oncological)
13.2.6.1.By Oncological (Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Others)
13.2.6.2.By Non-Oncological (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others)
13.2.7.By End User (Pharmaceutical & Biotechnology Companies, Clinical Laboratories, Academic & Research Institutions)
13.2.8.By Country
13.3.MEA: Country Analysis
13.3.1.Turkey Liquid Biopsy Market Outlook
13.3.1.1.Market Size & Forecast
13.3.1.1.1.By Value
13.3.1.2.Market Share & Forecast
13.3.1.2.1.By Offering
13.3.1.2.2.By Technology
13.3.1.2.3.By Workflow
13.3.1.2.4.By Sample
13.3.1.2.5.By Circulating Biomarker
13.3.1.2.6.By Application
13.3.1.2.7.By End User
13.3.2.Egypt Liquid Biopsy Market Outlook
13.3.2.1.Market Size & Forecast
13.3.2.1.1.By Value
13.3.2.2.Market Share & Forecast
13.3.2.2.1.By Offering
13.3.2.2.2.By Technology
13.3.2.2.3.By Workflow
13.3.2.2.4.By Sample
13.3.2.2.5.By Circulating Biomarker
13.3.2.2.6.By Application
13.3.2.2.7.By End User
13.3.3.Saudi Arabia Liquid Biopsy Market Outlook
13.3.3.1.Market Size & Forecast
13.3.3.1.1.By Value
13.3.3.2.Market Share & Forecast
13.3.3.2.1.By Offering
13.3.3.2.2.By Technology
13.3.3.2.3.By Workflow
13.3.3.2.4.By Sample
13.3.3.2.5.By Circulating Biomarker
13.3.3.2.6.By Application
13.3.3.2.7.By End User
13.3.4.South Africa Liquid Biopsy Market Outlook
13.3.4.1.Market Size & Forecast
13.3.4.1.1.By Value
13.3.4.2.Market Share & Forecast
13.3.4.2.1.By Offering
13.3.4.2.2.By Technology
13.3.4.2.3.By Workflow
13.3.4.2.4.By Sample
13.3.4.2.5.By Circulating Biomarker
13.3.4.2.6.By Application
13.3.4.2.7.By End User
13.3.5.UAE Liquid Biopsy Market Outlook
13.3.5.1.Market Size & Forecast
13.3.5.1.1.By Value
13.3.5.2.Market Share & Forecast
13.3.5.2.1.By Offering
13.3.5.2.2.By Technology
13.3.5.2.3.By Workflow
13.3.5.2.4.By Sample
13.3.5.2.5.By Circulating Biomarker
13.3.5.2.6.By Application
13.3.5.2.7.By End User
14.Market Dynamics
14.1.Drivers
14.2.Challenges
15.Market Trends & Developments
16.Competitive Landscape (Inclusive of SWOT Analysis)
16.1.F. Hoffmann-La Roche AG
16.2.Thermo Fisher Scientific, Inc.
16.3.PerkinElmer Inc.
16.4.LungLife AI, Inc.
16.5.Illumina, Inc.
16.6.QIAGEN NV
16.7.NeoGenomics Laboratories, Inc.
16.8.Myriad Genetics, Inc.
16.9.Biocept, Inc.
16.10.Bio-Rad Laboratories, Inc.
16.11.Guardant Health Inc.
16.12.Natera, Inc.
16.13.Sysmex Corporation
16.14.Abcodia Ltd.
16.15.Dxcover Limited
17.Strategic Recommendations
18.About Us & Disclaimer

List of Figure
Figure 1: Global Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 3: Global Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 4: Global Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 5: Global Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 6: Global Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 7: Global Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 8: Global Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 9: Global Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 10: Global Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 11: Global Liquid Biopsy Market Share, By Region, By Value, 2017-2027F
Figure 12: Global Liquid Biopsy Market Share, By Company, By Value, 2017-2027F
Figure 13: Global Liquid Biopsy Market Map, By Offering, Market Size (USD Million) & Growth Rate (%), 2021
Figure 14: Global Liquid Biopsy Market Map, By Technology, Market Size (USD Million) & Growth Rate (%), 2021
Figure 15: Global Liquid Biopsy Market Map, By Workflow, Market Size (USD Million) & Growth Rate (%), 2021
Figure 16: Global Liquid Biopsy Market Map, By Sample, Market Size (USD Million) & Growth Rate (%), 2021
Figure 17: Global Liquid Biopsy Market Map, By Circulating Biomarker, Market Size (USD Million) & Growth Rate (%), 2021
Figure 18: Global Liquid Biopsy Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 19: Global Liquid Biopsy Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2021
Figure 20: Global Liquid Biopsy Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 21: North America Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 22: North America Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 23: North America Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 24: North America Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 25: North America Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 26: North America Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 27: North America Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 28: North America Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 29: North America Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 30: North America Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 31: North America Liquid Biopsy Market Share, By Country, By Value, 2017-2027F
Figure 32: United States Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 33: United States Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 34: United States Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 35: United States Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 36: United States Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 37: United States Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 38: United States Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 39: United States Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 40: United States Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 41: United States Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 42: Canada Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 43: Canada Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 44: Canada Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 45: Canada Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 46: Canada Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 47: Canada Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 48: Canada Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 49: Canada Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 50: Canada Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 51: Canada Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 52: Mexico Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 53: Mexico Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 54: Mexico Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 55: Mexico Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 56: Mexico Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 57: Mexico Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 58: Mexico Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 59: Mexico Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 60: Mexico Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 61: Mexico Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 62: Europe Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 63: Europe Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 64: Europe Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 65: Europe Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 66: Europe Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 67: Europe Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 68: Europe Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 69: Europe Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 70: Europe Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 71: Europe Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 72: Europe Liquid Biopsy Market Share, By Country, By Value, 2017-2027F
Figure 73: Germany Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 74: Germany Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 75: Germany Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 76: Germany Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 77: Germany Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 78: Germany Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 79: Germany Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 80: Germany Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 81: Germany Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 82: Germany Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 83: France Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 84: France Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 85: France Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 86: France Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 87: France Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 88: France Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 89: France Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 90: France Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 91: France Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 92: France Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 93: United Kingdom Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 94: United Kingdom Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 95: United Kingdom Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 96: United Kingdom Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 97: United Kingdom Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 98: United Kingdom Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 99: United Kingdom Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 100: United Kingdom Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 101: United Kingdom Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 102: United Kingdom Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 103: Italy Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 104: Italy Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 105: Italy Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 106: Italy Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 107: Italy Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 108: Italy Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 109: Italy Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 110: Italy Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 111: Italy Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 112: Italy Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 113: Spain Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 114: Spain Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 115: Spain Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 116: Spain Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 117: Spain Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 118: Spain Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 119: Spain Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 120: Spain Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 121: Spain Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 122: Spain Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 123: Netherlands Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 124: Netherlands Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 125: Netherlands Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 126: Netherlands Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 127: Netherlands Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 128: Netherlands Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 129: Netherlands Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 130: Netherlands Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 131: Netherlands Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 132: Netherlands Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 133: Belgium Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 134: Belgium Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 135: Belgium Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 136: Belgium Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 137: Belgium Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 138: Belgium Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 139: Belgium Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 140: Belgium Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 141: Belgium Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 142: Belgium Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 143: Denmark Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 144: Denmark Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 145: Denmark Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 146: Denmark Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 147: Denmark Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 148: Denmark Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 149: Denmark Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 150: Denmark Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 151: Denmark Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 152: Denmark Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 153: Asia Pacific Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 154: Asia Pacific Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 155: Asia Pacific Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 156: Asia Pacific Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 157: Asia Pacific Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 158: Asia Pacific Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 159: Asia Pacific Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 160: Asia Pacific Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 161: Asia Pacific Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 162: Asia Pacific Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 163: Asia Pacific Liquid Biopsy Market Share, By Country, By Value, 2017-2027F
Figure 164: China Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 165: China Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 166: China Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 167: China Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 168: China Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 169: China Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 170: China Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 171: China Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 172: China Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 173: China Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 174: India Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 175: India Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 176: India Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 177: India Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 178: India Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 179: India Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 180: India Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 181: India Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 182: India Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 183: India Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 184: Japan Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 185: Japan Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 186: Japan Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 187: Japan Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 188: Japan Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 189: Japan Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 190: Japan Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 191: Japan Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 192: Japan Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 193: Japan Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 194: South Korea Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 195: South Korea Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 196: South Korea Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 197: South Korea Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 198: South Korea Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 199: South Korea Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 200: South Korea Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 201: South Korea Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 202: South Korea Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 203: South Korea Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 204: Australia Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 205: Australia Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 206: Australia Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 207: Australia Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 208: Australia Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 209: Australia Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 210: Australia Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 211: Australia Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 212: Australia Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 213: Australia Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 214: New Zealand Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 215: New Zealand Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 216: New Zealand Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 217: New Zealand Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 218: New Zealand Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 219: New Zealand Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 220: New Zealand Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 221: New Zealand Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 222: New Zealand Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 223: New Zealand Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 224: South America Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 225: South America Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 226: South America Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 227: South America Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 228: South America Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 229: South America Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 230: South America Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 231: South America Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 232: South America Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 233: South America Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 234: South America Liquid Biopsy Market Share, By Country, By Value, 2017-2027F
Figure 235: Brazil Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 236: Brazil Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 237: Brazil Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 238: Brazil Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 239: Brazil Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 240: Brazil Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 241: Brazil Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 242: Brazil Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 243: Brazil Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 244: Brazil Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 245: Argentina Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 246: Argentina Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 247: Argentina Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 248: Argentina Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 249: Argentina Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 250: Argentina Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 251: Argentina Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 252: Argentina Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 253: Argentina Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 254: Argentina Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 255: Colombia Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 256: Colombia Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 257: Colombia Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 258: Colombia Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 259: Colombia Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 260: Colombia Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 261: Colombia Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 262: Colombia Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 263: Colombia Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 264: Colombia Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 265: Middle East & Africa Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 266: Middle East & Africa Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 267: Middle East & Africa Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 268: Middle East & Africa Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 269: Middle East & Africa Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 270: Middle East & Africa Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 271: Middle East & Africa Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 272: Middle East & Africa Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 273: Middle East & Africa Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 274: Middle East & Africa Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 275: Middle East & Africa Liquid Biopsy Market Share, By Country, By Value, 2017-2027F
Figure 276: Turkey Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 277: Turkey Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 278: Turkey Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 279: Turkey Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 280: Turkey Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 281: Turkey Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 282: Turkey Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 283: Turkey Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 284: Turkey Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 285: Turkey Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 286: Egypt Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 287: Egypt Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 288: Egypt Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 289: Egypt Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 290: Egypt Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 291: Egypt Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 292: Egypt Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 293: Egypt Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 294: Egypt Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 295: Egypt Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 296: Saudi Arabia Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 297: Saudi Arabia Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 298: Saudi Arabia Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 299: Saudi Arabia Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 300: Saudi Arabia Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 301: Saudi Arabia Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 302: Saudi Arabia Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 303: Saudi Arabia Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 304: Saudi Arabia Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 305: Saudi Arabia Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 306: South Africa Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 307: South Africa Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 308: South Africa Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 309: South Africa Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 310: South Africa Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 311: South Africa Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 312: South Africa Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 313: South Africa Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 314: South Africa Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 315: South Africa Liquid Biopsy Market Share, By End User, By Value, 2017-2027F
Figure 316: UAE Liquid Biopsy Market Size, By Value (USD Million), 2017-2027F
Figure 317: UAE Liquid Biopsy Market Share, By Offering, By Value, 2017-2027F
Figure 318: UAE Liquid Biopsy Market Share, By Technology, By Value, 2017-2027F
Figure 319: UAE Liquid Biopsy Market Share, By Workflow, By Value, 2017-2027F
Figure 320: UAE Liquid Biopsy Market Share, By Sample, By Value, 2017-2027F
Figure 321: UAE Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 322: UAE Liquid Biopsy Market Share, By Application, By Value, 2017-2027F
Figure 323: UAE Liquid Biopsy Market Share, By Application, By Oncological, By Value, 2017-2027F
Figure 324: UAE Liquid Biopsy Market Share, By Application, By Non-Oncological, By Value, 2017-2027F
Figure 325: UAE Liquid Biopsy Market Share, By End User, By Value, 2017-2027F

Report Title: Global Liquid Biopsy Market By Offering (Testing Services, Kits, Platform, Other consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Others), By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management), By Sample (Blood, Urine, Saliva, Others), By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Cell-free Nucleic Acids, Exosomes & Extracellular Vesicles), By Application (Oncological and Non-oncological), By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), By Region Competition Forecast & Opportunities, 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region